Form 4 holding
Chief Business Officer
Lyell Immunopharma, Inc.
- Security class
- Common Stock
- Shares / value
- 162,500
- Estimated value
- $114,000
- Report date
- 10 Feb 2025
- Price
- $2.28
- Ownership
- Direct
Matthew Lang - Chief Business Officer at Lyell Immunopharma, Inc.
Issuer-level insider activity
- Role
- Chief Business Officer
- Issuer ticker
- LYEL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Matthew Lang since 12 Aug 2025
Reported holdings for Matthew Lang in Lyell Immunopharma, Inc.
Form 4 holding
Chief Business Officer
Lyell Immunopharma, Inc.
- Security class
- Option (right to buy)
- Shares / value
- 56,250
- Estimated value
- Report date
- 10 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Matthew Lang in Lyell Immunopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.